Nordea Investment Management AB Purchases 12,339 Shares of DaVita Inc. (NYSE:DVA)

Nordea Investment Management AB grew its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 4.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 264,535 shares of the company's stock after acquiring an additional 12,339 shares during the period. Nordea Investment Management AB owned about 0.32% of DaVita worth $39,712,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. TD Asset Management Inc raised its position in shares of DaVita by 2.0% in the 2nd quarter. TD Asset Management Inc now owns 14,046 shares of the company's stock worth $1,946,000 after acquiring an additional 278 shares in the last quarter. National Bank of Canada FI grew its holdings in DaVita by 8.7% during the second quarter. National Bank of Canada FI now owns 33,356 shares of the company's stock worth $4,618,000 after buying an additional 2,674 shares in the last quarter. Strategic Financial Concepts LLC bought a new position in shares of DaVita during the second quarter valued at about $79,000. Acadian Asset Management LLC bought a new stake in DaVita in the 2nd quarter worth about $212,000. Finally, Caprock Group LLC purchased a new stake in DaVita in the 2nd quarter valued at about $276,000. Institutional investors and hedge funds own 90.12% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on DVA. Truist Financial lifted their target price on DaVita from $165.00 to $175.00 and gave the stock a "hold" rating in a research note on Monday, October 7th. Barclays boosted their target price on shares of DaVita from $150.00 to $164.00 and gave the company an "equal weight" rating in a research note on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $161.80.

DaVita Stock Performance

Shares of NYSE DVA traded up $1.12 during midday trading on Wednesday, hitting $153.81. The company's stock had a trading volume of 502,723 shares, compared to its average volume of 571,464. The stock has a fifty day moving average price of $155.13 and a 200 day moving average price of $151.88. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78. DaVita Inc. has a one year low of $103.40 and a one year high of $169.51. The firm has a market capitalization of $12.61 billion, a price-to-earnings ratio of 16.59, a P/E/G ratio of 0.86 and a beta of 0.92.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The company had revenue of $3.26 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the previous year, the firm posted $2.85 earnings per share. The business's revenue for the quarter was up 4.6% compared to the same quarter last year. On average, research analysts forecast that DaVita Inc. will post 9.71 EPS for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.